Robustness of a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer: assessing for systematic bias due to age, race, ethnicity, prostate volume, medication use, or imaging acquisition parameters
Deondre D Do, Mariluz Rojo Domingo, Christopher C Conlin, Ian Matthews, Karoline Kallis, Madison T Baxter, Courtney Ollison, Yuze Song, George Xu, Allison Y Zhong, Aditya Bagrodia, Tristan Barrett, Matthew Cooperberg, Felix Feng, Michael E Hahn, Mukesh Harisinghani, Gary Hollenberg, Juan Javier-Desloges, Sophia C Kamran, Christopher J Kane, Dimitri Kessler, Joshua Kuperman, Kang-Lung Lee, Jonathan Levine, Michael A Liss, Daniel JA Margolis, Paul M Murphy, Nabih Nakrour, Michael A Ohliger, Thomas Osinski, Anthony J Pamatmat, Isabella R Pompa, Rebecca Rakow-Penner, Jacob L Roberts, Karan Santhosh, Ahmed S Shabaik, David Song, Clare M Tempany, Shaun Trecarten, Natasha Wehrli, Eric P Weinberg, Sean Woolen, Anders M Dale, Tyler M Seibert
medRxiv 2024.09.10.24313042; doi: https://doi.org/10.1101/2024.09.10.24313042